Do we, as reproductive health care providers, follow our own informed counsel as we hope our patients do? Or do we suffer from similar human vulnerabilities, such as “heat of the moment” temptations or hopeful trust in statistical odds of avoiding consequences? A recent study we undertook gives insight into that question.
Venous thromboembolism (VTE) is a rare complication with hormonal contraceptives. However, the risk is not zero. And unfortunately, the condition may be overlooked when it occurs in an otherwise healthy young woman. When overlooked, VTE can become dangerous.
Among teens aged 15-19 years attending Title X clinics, LARC use increased from 0.4% in 2005 to 7.1% in 2013, reports the Centers for Disease Control and Prevention. Why not higher? Commonly cited barriers include cost (60%), staff concerns about IUD use among teens (47%), and lack of training on insertion of implants (47%) and IUDs (38%).
The “Contraceptive Technology” conferences will help you synthesize the data and translate the evidence into clinical “pearls” you can put directly into practice. With an array of Preconferences delving into selected specialty areas of interest, plenary sessions focusing on the “hottest” topics, a thought-provoking luncheon presentation, and 30 dynamic, interactive Concurrent Sessions, including hands-on workshops…this conference is certain to improve your clinical practice and expand your network of colleagues. Read more